January 18, 2019
LILLY REPORTS RESULTS OF PHASE 3 SOFT TISSUE SARCOMA
Today, Eli Lilly reported that the results of their Phase 3 study of olaratumab (LARTRUVO®) in combination with doxorubicin versus doxorubicin alone in patients with advanced or metastatic soft tissue …
Read more